Treatment of primary liver graft non-function with prostaglandin E1 results in increased graft and patient survival.
Paul D. Greig(University of Toronto), Laurie Blendis, Graham M. Woolf(University of Toronto), M Ettles(University of Toronto), Bruce Taylor(University of London), Michaël Abécassis(University of Arizona), B Langer(University of Toronto), Riccardo Superina(Lurie Children's Hospital), M. F. X. Glynn(Toronto General Hospital), Steven M. Strasberg(Barnes-Jewish Hospital)
PubMed
February 1, 1989
Cited by 27
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)
|Surgery|2011|2.3k
Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver Surgery
|Surgery|2011|1.9k
The International Position on Laparoscopic Liver Surgery
|Annals of Surgery|2009|1.5k